INVESTMENT IN, AND NOTE RECEIVABLE FROM MELT PHARMACEUTICALS, INC. - RELATED PARTY TRANSACTIONS (Tables)

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

SCHEDULE OF CONDENSED INCOME STATEMENT

The unaudited condensed results of operations information of Melt is summarized below:

	For the Nine Months Ended September 30,
	2022			2021
Revenues, net	$	-		$	-
Loss from operations		(9,064,000	)		(3,765,000	)
Net loss	$	(10,562,000	)	$	(3,907,000	)

SUMMARY OF CONDENSED BALANCE SHEET

The unaudited condensed balance sheet information of Melt is summarized below:

	At			At
	September 30, 2022			December 31, 2021
Current assets	$	3,638,000		$	11,278,000
Non-current assets		994,000			-
Total assets	$	4,632,000		$	11,278,000
Total liabilities	$	19,207,000		$	15,732,000
Total preferred stock and stockholders’ deficit		(14,575,000	)		(4,454,000	)
Total liabilities and stockholders’ equity	$	4,632,000		$	11,278,000